Protective effects of local administration of ciprofloxacin on the risk of pneumococcal meningitis after cochlear implantation

Laryngoscope

Volumn 116, Issue 12, 2006, Pages 2138-2144

  Wei, Benjamin P C ^a   Robins Browne, Roy M ^a   Shepherd, Robert K ^a   Azzopardi, Kristy ^a   Clark, Graeme M ^a   O'Leary, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Ciprofloxacin; Cochlear implantation; Pneumococcal meningitis; Sodium hyaluronate; Streptococcus pneumoniae

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; HYALURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MENINGITIS; COCHLEA PROSTHESIS; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; ELECTRODE; ENVIRONMENTAL TEMPERATURE; HISTOPATHOLOGY; IMPLANTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION TIME; RISK MANAGEMENT; RISK REDUCTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; COCHLEAR IMPLANTATION; ELECTRODES, IMPLANTED; HYALURONIC ACID; MENINGITIS, PNEUMOCOCCAL; MODELS, ANIMAL; RATS; RATS, WISTAR; STREPTOCOCCUS PNEUMONIAE;

EID: 33845472892     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000243192.43574.81     Document Type: Article

References (15)

1. FDA. Public health web notification: risk of bacterial meningitis in children with cochlear implants. Available at: www.fda.gov/cdrh/safety/cochlear. html. Accessed July 9, 2006.
2. Reefhuis J, Honein MA, Whitney CG, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med 2003;349:435-445.
3. Wei BPC, Shepherd RK, Robins-Browne R, et al. Threshold shift: effects of cochlear implantation on the risk of pneumococcal meningitis post implantation. Otolaryngol Head Neck Surg 2006. Received AAO-HNSF/ARO Resident Research Award. In press.
4. Brownlee RE, Hulka GF, Prazma J, Pillsbury HC III. Ciprofloxacin. Use as a topical otic preparation. Arch Otolaryngol Head Neck Surg 1992;118:392-396.
5. Bagger-Sjoback D, Lundman L, Nilsson-Ehle I. Ciprofloxacin and the inner ear: a morphological and round window membrane permeability study. ORL J Otorhinolaryngol Relat Spec 1992;54:5-9.
6. Donnelly MJ, Cohen LT, Clark GM. Initial investigation of the efficacy and biosafety of sodium hyaluronate (Healon) as an aid to electrode array insertion. Ann Otol Rhinol Laryngol Suppl 1995;166:45-48.
7. Roland JT Jr, Magardino TM, Go JT, Hillman DE. Effects of glycerin, hyaluronic acid, and hydroxypropyl methylcellulose on the spiral ganglion of the guinea pig cochlea. Ann Otol Rhinol Laryngol Suppl 1995;166:64-68.
8. Wei BPC, Shepherd RK, Robins-Browne RM, et al. Pneumococcal meningitis: development of a new animal model. Otol Neurotol 2006;27:844-854.
9. Wei BP, Shepherd RK, Robins-Browne R, et al. Pneumococcal meningitis threshold model: a potential tool to assess infectious risk of new or existing inner ear surgical interventions. Otol Neurotol 2006. In press.
10. Salt AN, Ohyama K, Thalmann R. Radial communication between the perilymphatic scalae of the cochlea. II. Estimation by bolus injection of tracer into the sealed cochlea. Hear Res 1991;56:37-43.
11. Williams I, Venables WA, Lloyd D, et al. The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus. Microbiology 1997;143:2407-2413.
12. Koestner JA. Ciprofloxacin: a new fluoroquinolone. Am J Med Sc 1989;297:128-131.
13. Lutz H, Lenarz T, Gotz R. Ototoxicity of gyrase antagonist ciprofloxacin? Adv Otorhinolaryngol 1990;45:175-180.
14. Russell PT, Church CA, Jinn TH, et al. Effects of common topical otic preparations on the morphology of isolated ochlear outer hair cells. Acta Otolaryngol 2001;121:135-139.
15. Hampl JA, Weitzel A, Bonk C, et al. Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections. Infection 2003;31:109-111.